Nanologica is a nanotechnology company developing nanoporous silica particles for applications within life science. The company is world-leading in controlling the shape, size, and type of porosity of silica particles. This knowledge is applied within drug development and chromatography (a separation technique used in drug development and drug production). The company’s mission is to contribute to better and cheaper treatments for patients worldwide through the technology platform NLAB Silica™. Nanologica’s stock (NICA) is listed on Spotlight Stock Market. For further information, please visit www.nanologica.com.
Location: Sweden, Södertälje
Employees: 11-50
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | Flerie Inv... | flerie.com |
Mentions in press and media 9
| Date | Title | Description |
| 31.03.2022 | Nanologica deltar i konferenser för preparativ kromatografi | Nanologica deltar i konferenser för preparativ kromatografi Thu, Mar 31, 2022 11:28 CET Report this content Nanologica kommer att delta i flera kromatografikonferenser under våren i samband med lanseringen av bolagets silika för preparativ ... |
| 09.02.2022 | Nanologica : CEO Comment Q4 2021 | CEO Comment Q4 2021 February 9, 2022 CEO Comments AN EXCITING TIME AHEAD During the year, major changes have been made in the company's two business areas; in Chromatography, Nanologica now focuses mainly on preparative chromatography, and ... |
| 08.02.2022 | Nanologica : Year-End Report 2021 | Nanologica's Year-End Report 2021 February 8, 2022 Financial reports, Interim Reports FINANCIAL SUMMARY Net sales for the fourth quarter amounted to TSEK 676 (6,071) and for the full year to TSEK 12,914 (16,135) The operating result for the... |
| 19.01.2022 | Nanologica : Signs Credit Line with Main Owner | Nanologica Signs Credit Line with Main Owner January 19, 2022 Press releases, Regulatory press releases Nanologica AB has signed a credit line of up to MSEK 50 with the company's main owner Flerie Invest AB. The aim is to cover the company'... |
| 29.10.2021 | Nanologica Announces the Nomination Committee for the 2022 Annual General Meeting | Nanologica Announces the Nomination Committee for the 2022 Annual General Meeting October 29, 2021 Press releases, Regulatory press releases In accordance with the decision taken at the annual general meeting on May 27, 2021, the three larg... |
| 17.09.2021 | Nanologica : Closes NIC-001 | Nanologica Closes NIC-001 September 17, 2021 Press releases, Regulatory press releases Nanologica AB has decided to close the project with the drug candidate NIC-001 for the treatment of gastroparesis before the planned clinical study begin... |
| 30.06.2021 | Nanologica : Exercise of Rights in Nanologica's Stock Option Program | Exercise of Rights in Nanologica's Stock Option Program June 30, 2021 News, Press releases, Regulatory press releases In Nanologica's stock option program 2018/21 exercise of rights in Nanologica's stock option program has increased the num... |
| 02.06.2021 | Nanologica Recruits VP Drug Development | Nanologica Recruits VP Drug Development Wed, Jun 02, 2021 08:44 CET Nanologica has recruited Ulf Ericsson as VP Drug Development as part of the strategy to enhance focus on the respiratory field and inhalation, within the business area Drug... |
| 11.11.2008 | Nanologica to make see-through solar cells | Now here’s an odd discovery I made today: Nanologica has created see-through solar cells that you can place on a building surface. The technology is pretty freaky. What you have is a “polarized” surface that lets in light allows some light ... |